UBS Maintains Buy on BioMarin Pharmaceutical Inc., Raises PT to $67.00
Tickers: BMRN
Get News First. Profit Faster
With Benzinga Professional get unlimited access to ALL content! PLUS:
- REALTIME NEWSFEED
- REALTIME AUDIO NEWS
- FULL CALENDAR SUITE
- CHAT WITH OUR NEWS DESK
RECENT PRO ALERTS
Sandler O'Neill Upgrades Shore Bancshares Inc to Buy, Raises PT to $8.75
09:42am - April 30, 2013Allied Nevada Says Underwriters Priced Offering of 14M Shares at $10.75/Share
09:40am - April 30, 2013Fitch Affirms Ratings on JC Penney; Outlook Negative
09:39am - April 30, 2013
Posted in: News, Price Target, Analyst Ratings